Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery

Mostrar otras versiones (1)

BACKGROUND: Schizophrenia is mostly a chronic disorder whose symptoms include psychosis, negative symptoms and cognitive dysfunction. Poor adherence is common and related relapse can impair outcomes. Long-acting injectable antipsychotics (LAIs) may promote treatment adherence and decrease the likeli...

Descripción completa

Detalles Bibliográficos
Autores principales: Arango, Celso, Fagiolini, Andrea, Gorwood, Philip, Kane, John M., Diaz-Mendoza, Sergio, Sahota, Navdeep, Correll, Christoph U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029086/
https://www.ncbi.nlm.nih.gov/pubmed/36945577
http://dx.doi.org/10.21203/rs.3.rs-2594278/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029086/
https://www.ncbi.nlm.nih.gov/pubmed/36945577
http://dx.doi.org/10.21203/rs.3.rs-2594278/v1

Ejemplares similares